Methadone appears to be superior to fentanyl for the treatment of neuropathic pain in patients with head and neck cancer.
The Indication for CTC ICPNQ is a valid instrument to distinguish the highest chemotherapy-induced peripheral neuropathy CTC grades from the lower CTC grades required to inform dose modification of chemotherapy decisions in clinical practice.
A study has found that duloxetine effectively decreases pain for patients with chemotherapy-related peripheral neuropathy, especially for those who received the drug as initial treatment.
What can be done to decrease the severity of peripheral neuropathy experienced by patients receiving chemotherapy?
A composite measure assessed peripheral neuropathy induced by vincristine reliably and with validity.
Neurocognitive impairment seems to occur in the presence of cardiopulmonary dysfunction.
Oxaliplatin, which has become the standard of care in advanced colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|